Submission of intimation of change in Designation of Director.

Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) Date: 31st August, 2026 The Deputy Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref: Scrip Code: 536565 Scrip Id: NOVELIX Respected Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held on 29th August, 2026, has approved the appointment of Mr. Gnana Prakash Gattu (DIN:00517921) as Whole time director of the Company for a period of five years with effect from 29th August, 2026 subject to the approval of the members of the Company in ensuing annual general meeting of the Company. Details as required as per Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 in respect of aforesaid appointment is given in ‘Annexure I’ to this letter. The Meeting was commenced at 03:00 P.M. and concluded at 04:55 P.M. We request you to take the aforesaid information on record for dissemination through your website. Thanking you Yours sincerely, For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) Annexure I Details as required as per Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. No. Disclosure Requirement Details 1. Reason for change viz. Change in Mr. Gnana Prakash Gattu is appointed Designation as Whole time director of the company with effect from 29th August, 2026. 2. Date of appointment & 29th August, 2026 Term of Appointment Mr. Gnana Prakash Gattu is appointed as Whole time director of the company for a period of 5 years subject to approval of the members of the Company in the ensuing annual general meeting. 3. Name of the listed entities in which Nil resigning director holds directorship including category of directorship and membership of committee, if any 4. Brief Profile (In case of appointment) Mr. Gattu Gnana Prakash is a graduate from IIT-Chennai and having more than 25 years of experience in management and information technology. 5. Disclosure of Relationship between Mr. Gattu Gnana Prakash is not related Directors {in case of appointment of to any of the Directors or Key Director) Managerial Personnel. Mr. Gattu Gnana Prakash belongs to Promoters and Promoter group of the Company. 6. Information as required under BSE Mr. Gattu Gnana Prakash is not circular no. LIST/COMP/14/2018-19, debarred from holding the office of dated June 20, 2018. Director by any SEBI order or any other such authority. Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com